US and European activist investors are targeting some of the UK's biggest publicly traded companies, taking advantage of slumping stock prices to push for company breakups and other changes.
Florida-based hedge fund Elliott Management is making waves at UK pharmaceutical giant GlaxoSmithKline and SSE, an electricity network and alternative energy provider. Daniel Loeb's Third Point is calling for a breakup of Shell. And Trian Fund Management, another well-known US activist hedge fund, headed by Nelson Peltz, owns a stake in...
Read more on fnlondon.com